State of the Science: Hot Flashes and Cancer, Part 1: Definition, Scope, Impact, Physiology, and Measurement

Acs, N., Vajo, Z., Demendi, C., Nadasy, G., Monos, E., & Szekacs, B. (2001). Estrogen improves impaired musculocutaneous vascular adrenergic reactivity in pharmacologically ovariectomized rats: A potential peripheral mechanism for hot flashes? Gynecological Endocrinology, 15, 68-73.

Aktan, E., Kaleli, B., & Sungurtekin, H. (1998). Do menopausal hot flashes have any significant effects on arterial blood gas measurements? Maturitas, 29, 225-227.

Bar-Or, O. (1998). Effects of age and gender on sweating pattern during exercise. International Journal of Sports Medicine, 19(Suppl. 2), S106-S107.

Bellino, F.L., & Wise, P.M. (2003). Nonhuman primate models of menopause workshop. Biology of Reproduction, 68, 10-18.

Berendsen, H.H. (2000). The role of serotonin in hot flushes. Maturitas, 36, 155-164.

Bethea, C.L., Mirkes, S.J., Shively, C.A., & Adams, M.R. (2000). Steroid regulation of tryptophan hydroxylase protein in the dorsal raphe of macaques. Biological Psychiatry, 47, 562-576.

Biglia, N., Cozzarella, M., Cacciari, F., Ponzone, R., Roagna, R., Maggiorotto, F., et al. (2003). Menopause after breast cancer: A survey on breast cancer survivors. Maturitas, 45, 29-38.

Blum, I., Vered, Y., Lifshitz, A., Harel, D., Blum, M., Nordenberg, Y., et al. (1996). The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal women. Israel Journal of Medical Sciences, 32, 1158-1162.

Bober, S.L., Hoke, L.A., Duda, R.B., Regan, M.M., & Tung, N.M. (2004). Decision-making about tamoxifen in women at high risk for breast cancer: Clinical and psychological factors. Journal of Clinical Oncology, 22, 4951-4957.

Cacioppo, J.T., Tassinary, L.G., & Berntson, G.G. (Eds.). (2000). Handbook of psychophysiology (2nd ed.). New York: Cambridge University.

Carpenter, J.S. (2000). [Laboratory monitoring of hot flashes]. Unpublished raw data.

Carpenter, J.S. (2001). The Hot Flash Related Daily Interference Scale: A tool for assessing the impact of hot flashes on quality of life following breast cancer. Journal of Pain and Symptom Management, 22, 979-989.

Carpenter, J.S., Andrykowski, M.A., Cordova, M., Cunningham, L., Studts, J., McGrath, P., et al. (1998). Hot flashes in postmenopausal women treated for breast carcinoma: Prevalence, severity, correlates, management, and relation to quality of life. Cancer, 82, 1682-1691.

Carpenter, J.S., Andrykowski, M.A., Freedman, R.R., & Munn, R. (1999). Feasibility and psychometrics of an ambulatory hot flash monitoring device. Menopause, 6, 209-215.

Carpenter, J.S., Azzouz, F., Monahan, P.O., Storniolo, A.M., & Ridner, S.H. (in press). Is sternal skin conductance monitoring a valid measure of hot flash intensity and/or hot flash distress? Menopause, 12(5).

Carpenter, J.S., Gautam, S., Freedman, R.R., & Andrykowski, M. (2001). Circadian rhythm of objectively recorded hot flashes in postmenopausal breast cancer survivors. Menopause, 8, 181-188.

Carpenter, J.S., Gilchrist, J.M., Chen, K., Gautam, S., & Freedman, R.R. (2004). Hot flashes, core body temperature, and metabolic parameters in breast cancer survivors. Menopause, 11, 375-381.

Carpenter, J.S., Johnson, D., Wagner, L., & Andrykowski, M. (2002). Hot flashes and related outcomes in breast cancer survivors and matched comparison women [Online exclusive]. Oncology Nursing Forum, 29, E16-E25.

Carpenter, J.S., Monahan, P.O., & Azzouz, F. (2004). Accuracy of subjective hot flush reports compared with continuous sternal skin conductance monitoring. Obstetrics and Gynecology, 104, 1322-1326.

Carpenter, J.S., Wells, N., Lambert, B., Watson, P., Slayton, T., Chak, B., et al. (2002). A pilot study of magnetic therapy for hot flashes after breast cancer. Cancer Nursing, 25, 104-109.

Charig, C.R., & Rundle, J.S. (1989). Flushing. Long-term side effect of orchiectomy in treatment of prostatic carcinoma. Urology, 33, 175-178.

Chen, J.T., Hirai, Y., Seimiya, Y., Hasumi, K., & Shiraki, M. (1993). Menopausal flushes and calcitonin-gene-related peptide. Lancet, 342, 49.

Chen, Y., Lu, X., Huang, Y., Xin, X., & Ye, X. (2002). [Changes of plasma serotonin precursor metabolite concentrations in postmenopausal women with hot flushes]. Zhonghua Fu Chan Ke Za Zhi, 37, 726-728.

Clover, A., & Ratsey, D. (2002). Homeopathic treatment of hot flushes: A pilot study. Homeopathy, 91, 75-79.

Cohen, S.M., Rousseau, M.E., & Carey, B.L. (2003). Can acupuncture ease the symptoms of menopause? Holistic Nursing Practice, 17, 295-299.

Couzi, R.J., Helzlsouer, K.J., & Fetting, J.H. (1995). Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. Journal of Clinical Oncology, 13, 2737-2744.

Day, R., Ganz, P.A., Costantino, J.P., Cronin, W.M., Wickerham, D.L., & Fisher, B. (1999). Health-related quality of life and tamoxifen in breast cancer prevention: A report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. Journal of Clinical Oncology, 17, 2659-2669.

de Bakker, I.P., & Everaerd, W. (1996). Measurement of menopausal hot flushes: Validation and cross-validation. Maturitas, 25, 87-98.

Dormire, S.L., & Carpenter, J.S. (2002). An alternative to Unibase/glycol as an effective nonhydrating electrolyte medium for the measurement of electrodermal activity. Psychophysiology, 39, 423-426.

Dormire, S.L., & Reame, N.K. (2003). Menopausal hot flash frequency changes in response to experimental manipulation of blood glucose. Nursing Research, 52, 338-343.

Finck, G., Barton, D.L., Loprinzi, C.L., Quella, S.K., & Sloan, J.A. (1998). Definitions of hot flashes in breast cancer survivors. Journal of Pain and Symptom Management, 16, 327-333.

Freedman, R.R. (1989). Laboratory and ambulatory monitoring of menopausal hot flashes. Psychophysiology, 26, 573-579.

Freedman, R.R. (1998). Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes. Fertility and Sterility, 70, 332-337.

Freedman, R.R. (2000a). Hot flashes revisited. Menopause, 7, 3-4.

Freedman, R.R. (2000b). Menopausal hot flashes. In R.A. Lobo, J. Kelsey, & R. Marcus (Eds.)Menopause: Biology and pathobiology (pp. 215-227). San Diego, CA: Academic Press.

Freedman, R.R. (2001). Physiology of hot flashes. American Journal of Human Biology, 13, 453-464.

Freedman, R.R., & Blacker, C.M. (2002). Estrogen raises the sweating threshold in postmenopausal women with hot flashes. Fertility and Sterility, 77, 487-490.

Freedman, R.R., & Dinsay, R. (2000). Clonidine raises the sweating threshold in symptomatic but not in asymptomatic postmenopausal women. Fertility and Sterility, 74, 20-23.

Freedman, R.R., & Krell, W. (1999). Reduced thermoregulatory null zone in postmenopausal women with hot flashes. American Journal of Obstetrics and Gynecology, 181, 66-70.

Freedman, R.R., Norton, D., Woodward, S., & Cornelissen, G. (1995). Core body temperature and circadian rhythm of hot flashes in menopausal women. Journal of Clinical Endocrinology and Metabolism, 80, 2354-2358.

Freedman, R.R., & Woodward, S. (1996). Core body temperature during menopausal hot flushes. Fertility and Sterility, 65, 1141-1144.

Gajdos, C., & Jordan, V.C. (2002). Selective estrogen receptor modulators as a new therapeutic drug group: Concept to reality in a decade. Clinical Breast Cancer, 2, 272-281.

Goldberg, R.M., Loprinzi, C.L., O'Fallon, J.R., Veeder, M.H., Miser, A.W., Mailliard, J.A., et al. (1994). Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. Journal of Clinical Oncology, 12, 155-158.

Gonzales, G.F., & Carrillo, C. (1993). Blood serotonin levels in postmenopausal women: Effects of age and serum oestradiol levels. Maturitas, 17, 23-29.

Guyton, A.C., & Hall, J.E. (2000). Textbook of medical physiology (10th ed.). Philadelphia: Saunders.

Halbreich, U., Rojansky, N., Palter, S., Tworek, H., Hissin, P., & Wang, K. (1995). Estrogen augments serotonergic activity in postmenopausal women. Biological Psychiatry, 37, 434-441.

Hammar, M., Ekblad, S., Lonnberg, B., Berg, G., Lindgren, R., & Wyon, Y. (1999). Postmenopausal women without previous or current vasomotor symptoms do not flush after abruptly abandoning estrogen replacement therapy. Maturitas, 31, 117-122.

Hammar, M., Frisk, J., Grimas, O., Hook, M., Spetz, A.C., & Wyon, Y. (1999). Acupuncture treatment of vasomotor symptoms in men with prostatic carcinoma: A pilot study. Journal of Urology, 161, 853-856.

Harris, P.F., Remington, P.L., Trentham-Dietz, A., Allen, C.I., & Newcomb, P.A. (2002). Prevalence and treatment of menopausal symptoms among breast cancer survivors. Journal of Pain and Symptom Management, 23, 501-509.

Holzbeierlein, J.M., Castle, E., & Thrasher, J.B. (2004). Complications of androgen deprivation therapy: Prevention and treatment. Oncology, 18, 303-309.

Holzbeierlein, J.M., McLaughlin, M.D., & Thrasher, J.B. (2004). Complications of androgen deprivation therapy for prostate cancer. Current Opinion in Urology, 14, 177-183.

James, G.D., Sievert, L.L., & Flanagan, E. (2004). Ambulatory blood pressure and heart rate in relation to hot flash experience among women of menopausal age. Annals of Human Biology, 31, 49-58.

Jin, Y., Hu, Z., Nguyen, A., Skaar, T., Flockhart, D., Hayes, D.F., et al. (2004, December). Estrogen receptor genotype predicts hot flash severity in patients with breast cancer. Paper presented at the annual meeting of the San Antonio Breast Cancer Symposium, San Antonio, TX.

Johnston, S.R. (2001). Endocrine manipulation in advanced breast cancer: Recent advances with SERM therapies. Clinical Cancer Research, 7(12, Suppl.), 4376s-4387s.

Kaciuba-Uscilko, H., & Grucza, R. (2001). Gender differences in thermo-regulation. Current Opinion in Clinical Nutrition and Metabolic Care, 4, 533-536.

Knobf, M.T. (2001). The menopausal symptom experience in young mid-life women with breast cancer. Cancer Nursing, 24, 201-210.

Kouriefs, C., Georgiou, M., & Ravi, R. (2002). Hot flushes and prostate cancer: Pathogenesis and treatment. BJU International, 89, 379-383.

Kronenberg, F. (1990). Hot flashes: Epidemiology and physiology. Annals of the New York Academy of Sciences, 592, 52-86.

Kronenberg, F. (1994). Hot flashes: Phenomenology, quality of life, and search for treatment options. Experimental Gerontology, 29, 319-336.

Kronenberg, F., Cote, L.J., Linkie, D.M., Dyrenfurth, I., & Downey, J.A. (1984). Menopausal hot flashes: Thermoregulatory, cardiovascular, and circulating catecholamine and LH changes. Maturitas, 6, 31-43.

Lomax, P., & Schonbaum, E. (1993). Postmenopausal hot flushes and their management. Pharmacology and Therapeutics, 57, 347-358.

Lo Presti, A., Ruvolo, G., Gancitano, R.A., & Cittadini, E. (2004). Ovarian function following radiation and chemotherapy for cancer. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 113(Suppl. 1), S33-S40.

Loprinzi, C.L., Pisansky, T.M., Fonseca, R., Sloan, J.A., Zahasky, K.M., Quella, S.K., et al. (1998). Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. Journal of Clinical Oncology, 16, 2377-2381.

Love, R.R. (1989). Tamoxifen therapy in primary breast cancer: Biology, efficacy, and side effects. Journal of Clinical Oncology, 7, 803-815.

Love, R.R., Cameron, L., Connell, B.L., & Leventhal, H. (1991). Symptoms associated with tamoxifen treatment in postmenopausal women. Archives of Internal Medicine, 151, 1842-1847.

Lu, N.Z., & Bethea, C.L. (2002). Ovarian steroid regulation of 5-HT1A receptor binding and G protein activation in female monkeys. Neuropsychopharmacology, 27, 12-24.

MacLeay, J.M., Lehmer, E., Enns, R.M., Mallinckrodt, C., Bryant, H.U., & Turner, A.S. (2003). Central and peripheral temperature changes in sheep following ovariectomy. Maturitas, 46, 231-238.

Matteson, S., Roscoe, J., Hickok, J., & Morrow, G.R. (2002). The role of behavioral conditioning in the development of nausea. American Journal of Obstetrics and Gynecology, 186(5, Suppl.), S239-S243.

Meldrum, D.R., Shamonki, I.M., Frumar, A.M., Tataryn, I.V., Chang, R.J., & Judd, H.L. (1979). Elevations in skin temperature of the finger as an objective index of postmenopausal hot flashes: Standardization of the technique. American Journal of Obstetrics and Gynecology, 135, 713-717.

Miller, H.G., & Li, R.M. (2004). Measuring hot flashes: Summary of a National Institutes of Health workshop. Mayo Clinic Proceedings, 79, 777-781.

Mohyi, D., Tabassi, K., & Simon, J. (1997). Differential diagnosis of hot flashes. Maturitas, 27, 203-214.

Molnar, G.W. (1975). Body temperatures during menopausal hot flashes. Journal of Applied Physiology, 38, 499-503.

Molnar, G.W. (1979). Investigation of hot flashes by ambulatory monitoring. American Journal of Physiology, 237(5), R306-R310.

Morales, L., Neven, P., Timmerman, D., Christiaens, M.R., Vergote, I., Van Limbergen, E., et al. (2004). Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients. Anti-Cancer Drugs, 15, 753-760.

Mouridsen, H., Gershanovich, M., Sun, Y., Perez-Carrion, R., Boni, C., Monnier, A., et al. (2001). Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: Results of a phase III study of the International Letrozole Breast Cancer Group. Journal of Clinical Oncology, 19, 2596-2606.

Nagamani, M., Kelver, M.E., & Smith, E.R. (1987). Treatment of menopausal hot flashes with transdermal administration of clonidine. American Journal of Obstetrics and Gynecology, 156, 561-565.

Nelesen, R., Krohn, P., & Dimsdale, J.E. (2004). Hot-flash hypotension. New England Journal of Medicine, 351, 1577-1579.

Nishiyama, T., Kanazawa, S., Watanabe, R., Terunuma, M., & Takahashi, K. (2004). Influence of hot flashes on quality of life in patients with prostate cancer treated with androgen deprivation therapy. International Journal of Urology, 11, 735-741.

Pasacreta, J.V., & McCorkle, R. (1998). Providing accurate information to women about tamoxifen therapy for breast cancer: Current indications, effects, and controversies. Oncology Nursing Forum, 25, 1577-1583.

Rosenberg, J., & Larsen, S.H. (1991). Hypothesis: Pathogenesis of postmenopausal hot flush. Medical Hypotheses, 35, 349-350.

Sabbioni, M.E., Bovbjerg, D.H., Jacobsen, P.B., Manne, S.L., & Redd, W.H. (1992). Treatment related psychological distress during adjuvant chemotherapy as a conditioned response. Annals of Oncology, 3, 393-398.

Savard, J., Davidson, J.R., Ivers, H., Quesnel, C., Rioux, D., Dupere, V., et al. (2004). The association between nocturnal hot flashes and sleep in breast cancer survivors. Journal of Pain and Symptom Management, 27, 513-522.

Schnirer, I. I., Yao, J.C., & Ajani, J.A. (2003). Carcinoid—A comprehensive review. Acta Oncologica, 42, 672-692.

Schow, D.A., Renfer, L.G., Rozanski, T.A., & Thompson, I.M. (1998). Prevalence of hot flushes during and after neoadjuvant hormonal therapy for localized prostate cancer. Southern Medical Journal, 91, 855-857.

Sipe, K., Leventhal, L., Burroughs, K., Cosmi, S., Johnston, G.H., & Deecher, D.C. (2004). Serotonin 2A receptors modulate tail-skin temperature in two rodent models of estrogen deficiency-related thermoregulatory dysfunction. Brain Research, 1028, 191-202.

Sloan, J.A., Loprinzi, C.L., Novotny, P.J., Barton, D.L., Lavasseur, B.I., & Windschitl, H. (2001). Methodologic lessons learned from hot flash studies. Journal of Clinical Oncology, 19, 4280-4290.

Spetz, A.C., Hammar, M., Lindberg, B., Spangberg, A., & Varenhorst, E. (2001). Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation for metastatic carcinoma of the prostate. Journal of Urology, 166, 517-520.

Spetz, A.C., Hammar, M.L., & Varenhorst, E. (2003). Hot flushes in men—Prevalence and possible mechanisms [Abstract]. Menopause, 10, 594.

Spetz, A.C., Zetterlund, E.L., Varenhorst, E., & Hammar, M. (2003). Incidence and management of hot flashes in prostate cancer. Journal of Supportive Oncology, 1(4), 263-273.

Stanford, J.L., Hartge, P., Brinton, L.A., Hoover, R.N., & Brookmeyer, R. (1987). Factors influencing the age at natural menopause. Journal of Chronic Diseases, 40, 995-1002.

Stearns, V., Ullmer, L., Lopez, J.F., Smith, Y., Isaacs, C., & Hayes, D. (2002). Hot flushes. Lancet, 360, 1851-1861.

Stein, K.D., Jacobsen, P.B., Hann, D.M., Greenberg, H., & Lyman, G. (2000). Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer. Journal of Pain and Symptom Management, 19, 436-445.

Stone, A.A., Shiffman, S., Schwartz, J.E., Broderick, J.E., & Hufford, M.R. (2002). Patient non-compliance with paper diaries. BMJ, 324, 1193-1194.

Swain, S., Santen, R., Burger, H., & Pritchard, K. (Eds.). (1999a). Treatment of estrogen deficiency symptoms in women surviving breast cancer. Part 1: Defining the problem. Proceedings of a conference held at the Boar's Head Inn, Charlottesville, Virginia. September 21-23, 1997. Oncology, 13, 109-124.

Swain, S., Santen, R., Burger, H., & Pritchard, K. (Eds.). (1999b). Treatment of estrogen deficiency symptoms in women surviving breast cancer. Part 2: Hormone replacement therapy and breast cancer. Proceedings of a conference held at the Boar's Head Inn, Charlottesville, Virginia. September 21-23, 1997. Oncology, 13, 245-257.

Swain, S., Santen, R., Burger, H., & Pritchard, K. (Eds.). (1999c). Treatment of estrogen deficiency symptoms in women surviving breast cancer. Part 3: Prevention of osteoporosis and CV effects of estrogens and antiestrogens. Proceedings of a conference held at the Boar's Head Inn, Charlottesville, Virginia. September 21-23, 1997. Oncology, 13, 397-412.

Swain, S., Santen, R., Burger, H., & Pritchard, K. (Eds.). (1999d). Treatment of estrogen deficiency symptoms in women surviving breast cancer. Part 4: Urogenital atrophy, vasomotor instability, sleep disorders, and related symptoms. Proceedings of a conference held at the Boar's Head Inn, Charlottesville, Virginia. September 21-23, 1997. Oncology, 13, 551-563.

Swain, S., Santen, R., Burger, H., & Pritchard, K. (Eds.). (1999e). Treatment of estrogen deficiency symptoms in women surviving breast cancer. Part 5: Selective estrogen receptor modulators and hormone replacement therapy. Proceedings of a conference held at the Boar's Head Inn, Charlottesville, Virginia. September 21-23, 1997. Oncology, 13, 721-732.

Swain, S., Santen, R., Burger, H., & Pritchard, K. (Eds.). (1999f). Treatment of estrogen deficiency symptoms in women surviving breast cancer. Part 6: Executive summary and consensus statement. Proceedings of a conference held at the Boar's Head Inn, Charlottesville, Virginia. September 21-23, 1997. Oncology, 13, 859-872.

Tataryn, I.V., Lomax, P., Bajorek, J.G., Chesarek, W., Meldrum, D.R., & Judd, H.L. (1980). Postmenopausal hot flushes: A disorder of thermoregulation. Maturitas, 2, 101-107.

Tataryn, I.V., Lomax, P., Meldrum, D.R., Bajorek, J.G., Chesarek, W., & Judd, H.L. (1981). Objective techniques for the assessment of postmenopausal hot flashes. Obstetrics and Gynecology, 57, 340-344.

Tataryn, I.V., Meldrum, D.R., Lu, K.H., Frumar, A.M., & Judd, H.L. (1979). LH, FSH and skin temperature during the menopausal hot flash. Journal of Clinical Endocrinology and Metabolism, 49, 152-154.

Thompson, E.A., & Reilly, D. (2003). The homeopathic approach to the treatment of symptoms of oestrogen withdrawal in breast cancer patients. A prospective observational study. Homeopathy, 92, 131-134.

U.S. Department of Health and Human Services. (2003). Estrogen and estrogen/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms—Recommendations for clinical evaluation: Draft guidance. Rockville, MD: U.S. Food and Drug Administration Center for Drug Evaluation and Research.

Valentini, A., Petraglia, F., De Vita, D., Nappi, C., Margutti, A., degli Uberti, E.C., et al. (1996). Changes of plasma calcitonin gene-related peptide levels in postmenopausal women. American Journal of Obstetrics and Gynecology, 175(3, Pt. 1), 638-642.

Woods, N.F., Mitchell, E.S., Viernes, H., Janssen, P., & Farrin, F. (2004, October). CYP17, CYP19, and ESR polymorphisms and symptoms during the menopausal transition: Observations from the Seattle Midlife Women's Health Study. Paper presented at the meeting of the North American Menopause Society, Washington, DC.

Woodward, S., Greville, H., & Freedman, R.R. (1995). Ventilatory response during menopausal hot flashes. Menopause, 2, 81-88.

Wyon, Y., Frisk, J., Lundeberg, T., Theodorsson, E., & Hammar, M (1998). Postmenopausal women with vasomotor symptoms have increased urinary excretion of calcitonin gene-related peptide. Maturitas, 30, 289-294.

Wyon, Y., Lindgren, R., Lundeberg, T., & Hammar, M. (1995). Effects of acupuncture on climacteric vasomotor symptoms, quality of life, and urinary excretion of neuropeptides among postmenopausal women. Menopause, 2, 3-12.

Wyon, Y., Spetz, A.C., Hammar, M., Theodorsson, E., & Varenhorst, E. (2001). Urinary excretion of calcitonin gene-related peptide in males with hot flushes after castration for carcinoma of the prostate. Scandinavian Journal of Urology and Nephrology, 35, 92-96.

Wyon, Y.A., Spetz, A.C., Theodorsson, G.E., & Hammar, M.L. (2000). Concentrations of calcitonin gene-related peptide and neuropeptide Y in plasma increase during flushes in postmenopausal women. Menopause, 7, 25-30.

Yuzurihara, M., Ikarashi, Y., Noguchi, M., Kase, Y., Takeda, S., & Aburada, M. (2003). Involvement of calcitonin gene-related peptide in elevation of skin temperature in castrated male rats. Urology, 62, 947-951.

Yuzurihara, M., Ikarashi, Y., Noguchi, M., Kase, Y., Takeda, S., & Aburada, M. (2004). Prevention by 17beta-estradiol and progesterone of calcitonin gene-related peptide-induced elevation of skin temperature in castrated male rats. Urology, 64, 1042-1047.